ESSA Pharma Inc.

CIK 1633932 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ESSA Pharma Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2025SCHEDULE 13G/A0001214659-25-016682
Nov 14, 2025EFFECT9999999995-25-003286
Nov 14, 2025SCHEDULE 13G/A0001214659-25-016689
Oct 28, 202515-12G0001104659-25-102922
Oct 15, 202540001104659-25-099650
Oct 15, 2025S-8 POS0001104659-25-099616
Oct 15, 2025S-8 POS0001104659-25-099613
Oct 15, 2025S-8 POS0001104659-25-099617
Oct 15, 202540001104659-25-099655
Oct 15, 2025S-8 POS0001104659-25-099615
Oct 15, 202540001104659-25-099644
Oct 15, 202540001104659-25-099652
Oct 15, 202540001104659-25-099657
Oct 15, 202540001104659-25-099647
Oct 15, 202540001104659-25-099659
Oct 15, 2025POS AM0001104659-25-099619
Oct 15, 2025S-8 POS0001104659-25-099618
Oct 14, 202540000921895-25-002742
Oct 14, 2025SCHEDULE 13D/A0000921895-25-002741
Oct 9, 20258-K0001104659-25-098078
Oct 9, 202525-NSE0001354457-25-001005
Oct 7, 2025SCHEDULE 13G/A0000895421-25-000531
Oct 6, 20258-K0001104659-25-097168
Oct 3, 20258-K0001104659-25-096306
Oct 3, 2025DEFA14A0001104659-25-096311